Halozyme Therapeutics | Betriebsaufwand



Operating Expenses Veränderung Datum
Acadia Pharmaceuticals USD 106.1M 112.66M 2024-12
Agios Pharmaceuticals USD 115.35M 20.41M 2025-03
Alnylam Pharmaceuticals USD 576.11M 122.21M 2025-03
Amarin USD 67.47M 549K 2024-09
Amgen USD 6.86B 85M 2025-03
Baxter International USD 3.19B 644M 2024-12
Cytokinetics USD 155.97M 14.7M 2024-12
DBV Technologies USD 31.4M 3.6M 2024-09
Eli Lilly USD 7.32B 1.06B 2025-03
Halozyme Therapeutics USD 122.51M 4.38M 2024-12
Indivior 200M 193M 2025-03
Ionis Pharmaceuticals USD 278M 59.4M 2025-03
MannKind USD 63.68M 11.62M 2024-12
Pfizer USD 10.05B 8.12B 2025-03
United Therapeutics USD 411.6M 33.4M 2025-03



Halozyme Therapeutics Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.